An Antiviral drug shows benefit: Story behind the story

Most of us watched the news of Dr. Anthony Fauci on April 29, 2020 announcing positive results of the clinical trial of the antiviral drug remdesivir. This positive news was like a ray of bright sunshine suddenly peeking through the dark clouds that had hung over the nation for last two months. It looks like that we have a winner. As good a news as this is, it is still preliminary and not the magic bullet that we are hoping for. So, I spent hours this morning digging through the sources and here is the story behind the story. The Story: The National Institute of Allergy and Infectious Diseases (NIAID, a division of the NIH, USA) sponsored clinical trial shows remdesivir accelerates recovery from advanced COVID-19. The NIH News Release April 29. 2020. Story behind the story: The NIAID had launched a multicenter clinical trial of the drug remdesivir in February 2020 in 100 testing sites globally. The drug, given intravenously, was to be tested in hospitalized...